Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 12—December 2004
Dispatch

Protective Effectiveness of Hantavirus Vaccine

Keeho Park*Comments to Author , Chang Soo Kim†, and Ki-Tae Moon‡
Author affiliations: *National Cancer Center, Goyang, Republic of Korea; †Republic of Korea Army, Gyeryong, Republic of Korea; ‡Yonsei University College of Medicine, Seoul, Republic of Korea

Main Article

Table

Characteristics of patients and matched controlsa

Characteristic No. doses (matched sets)
3 (31)
 2 (38)
 1 (41)
Patients Controls Patients Controls Patients Controls
Median age (y) 
(mean ± SD) 22.0 
(23.2 ± 3.5) 22.0 
(22.0 ± 3.6) 22.0 
(23.2 ± 3.1) 21.0 
(22.0 ± 2.1) 22.0 
(23.4 ± 3.8) 21.0 
(22.2 ± 0.7)
% vaccinated 6.5 32.3 23.7 39.5 29.3 36.6

aAll participants were men.

Main Article

Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external